drugset / Trial / NCT07662330

Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

NCT07662330 ↗

Recruiting 50 enrolled Shanghai 10th People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the effect of spermidine supplementation on lipid profile changes in individuals with overweight or obesity accompanied by hyperlipidemia. Analyze the impact of spermidine on metabolic parameters and assess the safety of spermidine supplementation, including liver and kidney function, gastrointestinal reactions, and other adverse effects.

Timeline

Start
2026-01-01
Primary completion
2026-12-31
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Spermidine Other / unclassified 10 mg Oral